Skip to main content
Premium Trial:

Request an Annual Quote

Microbiome Analysis Firm Phylagen Closes $14M Series A Round

NEW YORK (GenomeWeb) — Microbiome analysis firm Phylagen said today that it has closed a $14 million Series A round of financing.

The round was led by Cultivian Sandbox, Breakout Ventures, and Working Capital, with participation from 3M Ventures, Dolby Family Ventures, Agfunder, Duck Investors, Blackhorn Ventures, J-Angels, Western Technology Investment, and Arden Road Investments.

Founded in 2014, Phylagen has developed a microbiome analytics platform for supply chain management that combines next-generation sequencing and artificial intelligence. According to the San Francisco-based company, the platform can generate a microbial fingerprint for a product that can be used to trace its origin to a specific factory, farm, or warehouse.

Phylagen said it will use the new funding to expand its microbial forensics service and continue building its microbiome database.

"The environmental microbiome is the largest untapped dataset on the planet," Phylagen CEO Jessica Green said in a statement. "The global microbiome provides a fundamentally new type of geospatial data that we are leveraging to build a more transparent world."

In connection with the financing round, Breakout Ventures Partner and CSO Hemai Parthasarathy, Working Capital Partner Chemain Sanan, and Cultivian Sandbox Partner Dan Phillips have joined Phylagen's board of directors.